TCM Biotech International Corp. (TPE:4169)
Taiwan · Delayed Price · Currency is TWD 152.00
+3.50 (2.36%)
Sep 30, 2026, 1:30 PM CST
TCM Biotech International Market Cap
TCM Biotech International has a market cap or net worth of 9.87 billion as of September 29, 2026. Its market cap has increased by 45.28% in one year.
Market Cap
9.87B
Enterprise Value
8.68B
Revenue
701.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
152.00
ChartMarket Cap Chart
Since May 7, 2012, TCM Biotech International's market cap has increased from 1.37B to 9.87B, an increase of 621.13%. That is a compound annual growth rate of 14.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 9.87B | -3.43% |
| Dec 31, 2025 | 10.22B | 198.79% |
| Dec 31, 2024 | 3.42B | -0.52% |
| Dec 29, 2023 | 3.44B | 128.87% |
| Dec 30, 2022 | 1.50B | -17.43% |
| Dec 30, 2021 | 1.82B | 6.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lumosa Therapeutics | 13.48B |
| AP Biosciences | 13.46B |
| TWi Biotechnology | 10.46B |
| Polaris Group | 8.88B |
| Tanvex BioPharma | 8.03B |
| PharmaEngine | 7.97B |
| Locus Cell | 7.70B |
| Adimmune | 7.54B |